In Historic First, the Global Fund Procures African-Made First-Line HIV Treatment
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has reached a historic milestone by procuring – for the first time – a first-line HIV treatment manufactured in Africa. The treatment – lifesaving, quality-assured antiretroviral medicines (ARVs) called TLD (tenofovir, lamivudine and dolutegravir), prequalified by the World Health Organization – was sourced from a leading Kenyan pharmaceutical company and delivered to Mozambique. The volume supplied can treat over 72,000 people per year in the country.
Photo courtesy of Anna Shvets.
Source: The Global Fund (link opens in a new window)
- Categories
- Health Care
